Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Radhakrishnan V, Pai V, Rajaraman S. et al.
Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: an open-label, randomized phase 3 trial.

Pediatr Blood Cancer 2020;
67 (09) e28532
DOI: 10.1002/pbc.28532.

Bibliographische Angaben herunterladen

Aufrufen in: